TransMedics (TMDX) Operating Expenses (2018 - 2026)

TransMedics has reported Operating Expenses for 9 years, with the latest figure at $89.5 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 49.05% year-over-year to $89.5 million in Q2 2026; TTM through Jun 2026 was $310.7 million, a 28.89% increase from a year earlier, with the FY2025 full-year figure at $254.2 million, up 13.2% from the prior year.
• Operating Expenses was $89.5 million for Q2 2026 at TransMedics, up from $87.9 million in the prior quarter.
• The five-year high for Operating Expenses was $89.5 million in Q2 2026, with the low at $21.5 million in Q1 2022.
• Average Operating Expenses over 5 years is $52.0 million, with a median of $56.8 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 191.63% in 2023, then decreased 17.5% in 2024.
• Over 5 years, Operating Expenses stood at $27.5 million in 2022, then jumped by 64.91% to $45.3 million in 2023, then surged by 39.82% to $63.4 million in 2024, then increased by 13.84% to $72.1 million in 2025, then rose by 24.01% to $89.5 million in 2026.
• The last three Operating Expenses figures came in at $89.5 million (Q2 2026), $87.9 million (Q1 2026), and $72.1 million (Q4 2025), per Business Quant data.